News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
306 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17662)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (309)
2 (217)
3 (119)
4 (10)
5 (15)
6 (240)
7 (330)
8 (243)
9 (293)
10 (101)
11 (2)
12 (13)
13 (228)
14 (250)
15 (299)
16 (255)
17 (104)
18 (5)
19 (7)
20 (208)
21 (277)
22 (218)
23 (219)
24 (80)
25 (4)
26 (9)
27 (24)
28 (229)
29 (306)
30 (261)
31 (124)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Deals
BIOREM Reports First Quarter 2019 Financial Results
BIOREM Inc. announced results for the three month period ended March 31, 2019.
May 29, 2019
·
3 min read
Business
Moffitt Cancer Center Partners with TuHURA Biopharma Inc. to Develop a New Generation of Targeted Immunotherapies
Technology targeting tumor microenvironment will apply to a greater number of cancers and expand access to a larger population of cancer patients; and also shows potential to increase safety and effectiveness of immunotherapies for patients
May 29, 2019
·
4 min read
Pharm Country
WCG Introduces Unique Benchmarking Solution for Medical Device Companies
WCG’s KMR Group uses unparalleled data to accelerate study start-up in clinical trials
May 29, 2019
·
4 min read
BioMidwest
Healthcare Business Insights Announces 2018 Revenue Cycle Study Awards Recipients
Winners include Children’s Hospital of Philadelphia, Nebraska Medicine and Springhill Medical Center
May 29, 2019
·
3 min read
Pharm Country
DarioHealth to Present New Evidence of Digital Therapeutics Benefits at 2019 American Diabetes Association Conference
Outcomes of several new studies to be released, demonstrating improved life with diabetes.
May 29, 2019
·
4 min read
Business
Semma Therapeutics Appoints Mary Kay Fenton as Chief Financial Officer
Semma Therapeutics, Inc. announced that it has expanded its leadership team with the addition of Mary Kay Fenton as Chief Financial Officer.
May 29, 2019
·
2 min read
Business
Alnylam Announces New Leadership Appointments
Company Appoints Chief Human Resources Officer and Chief Scientific Officer
May 29, 2019
·
4 min read
Business
Finalists for the 2019 Catalyst Award for Top New Biotech Hire Announced
BioTalent Canada announced the three finalists for the Catalyst Award for Top New Hire.
May 29, 2019
·
5 min read
Business
Horizon Therapeutics plc and Invitae Corporation Launch Urea Cycle Disorder Genetic Testing Program
New program improves access and speed to receiving a diagnosis for people and extended family members who may be living with Urea Cycle Disorders
May 29, 2019
·
4 min read
Genetown
Casma Therapeutics Receives Grant from Michael J. Fox Foundation to Support Parkinson’s Drug Development
Casma Therapeutics, Inc. announced receipt of a Therapeutic Pipeline Program research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support development of a novel class of drugs to treat Parkinson’s disease.
May 29, 2019
·
3 min read
Previous
5 of 31
Next